News
Administering Shingrix previously required combining a lyophilised antigen with a liquid adjuvant from two separate vials.
The panel expressed concerns about the proposed doses of Blenrep (belantamab mafodotin) in GSK's marketing application, ...
With GSK kicking its research and development engine into high gear in recent years, a shuffling of the scientific priorities ...
GSK PLC closed 16.45% short of its 52-week high of £16.79, which the company reached on September 9th.
GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine ...
On a quest to bring its multiple myeloma antibody-drug conjugate (ADC) Blenrep back to the U.S. | Members of the FDA's Oncologic Drugs Advisory Committee voiced concerns with ocular toxicity side ...
Despite new market entrants in the form of Gilead's Livdelzi and Ipsen's Iqirvo, US gastroenterologists report nearly half of PBC patients suffer fro ...
GSK (GSK) stock in focus as the U.S. FDA approves a new prefilled syringe presentation of its shingles vaccine, Shingrix.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback